Sankyo's Antihypertensive Agent, ARB Olmesartan to Be Available in Central and South America.
Under the terms of the agreement, Schering-Plough will exclusively sell the agent in Argentina, Boilvia, Chile, Paraguay, Peru and Uruguay.
In addition, Sankyo will allow Schering-Plough to co-market the agent in Costa Rica, the Dominican Republic, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama and Venezuela.
Olmesartan is currently marketed in about 30 countries around the world.
Source: JCN http://www.japancorp.net
Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
|Printer friendly Cite/link Email Feedback|
|Publication:||JCNN News Summaries|
|Date:||Aug 9, 2005|
|Previous Article:||Ivy Cosmetics, Kitasato University Jointly Confirm That Shellac May Combat Skin Disorders.|
|Next Article:||Nippon Organon to Release Recombinant Follicle Stimulating Hormone Follistim.|